Stockreport

Revolution's on a pancreatic cancer winning streak. What comes next for the biotech? [Yahoo! Finance]

Revolution Medicines, Inc.  (RVMD) 
PDF Revolution Medicines has been on a roll this spring, delivering a string of clinical wins that have bolstered confidence in its platform, which broadly targets the RAS [Read more]